Dr. Erwin Charles Winkel III, MD

Dr. Winkel practices at Millennium Oncology in Houston, Texas.

Dr. Winkel's NPI, 1093874331, was assigned on December 6, 2006. Dr. Winkel graduated from Baylor College Of Medicine in 1989. Dr. Winkel holds Texas license H8520.

Dr. Winkel's primary practice is Millennium Oncology, at 17070 Red Oak Dr, Houston, TX 77090 in Harris County. The practice phone is (281) 298-8444.

Dr. Winkel's primary practice is Millennium Oncology in Houston, Texas. Dr. Winkel is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Millennium Physicians. Dmand AI also links Dr. Winkel to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Winkel practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Winkel's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Winkel is board certified in urology by the American Board of Urology. Dr. Winkel is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Winkel treats.

CMS data shows 8,989 Medicare services from Dr. Winkel across 21 procedure codes in 2024, for 818 Medicare patients. Medicare paid $188,892 for them.

CMS counts 818 Medicare patients who saw Dr. Winkel in 2024. The largest group is 75 to 84, with 346 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Winkel's median patient age at 71, with 20% women.

In 2024, Dr. Winkel wrote 4,260 Medicare Part D claims for 1,030 patients. 96% of them were for generic drugs. CMS names the drug for 4,095 of them, across 36 drugs with 11 or more claims each, at $237,699 in total drug cost. In 2023, CMS named 3,126 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Winkel for performance year 2024, reported as part of a group. Dr. Winkel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Winkel. Dr. Winkel's most frequent co-authors are Larry I. Lipshultz, MD and Francisco J. Orejuela, MD.

CMS Open Payments shows 384 general payments to Dr. Winkel from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Astellas Pharma US Inc paid the most, $995.

Dr. Winkel graduated from Baylor College Of Medicine in 1989.

Dr. Winkel is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.